Skip to content

Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

  • About
    • Supporter
    • Expert Index
    • Editorial Board
    • Editorial Team
    • Editorial Policy
  • Contact
  • Sign up

Visit

vjdementia
VJNeurology
Logo
  • Home (current)
  • Diseases
    Parkinson's Disease
    Multiple Sclerosis and Related Disorders
    Headache
    Amyotrophic Lateral Sclerosis
    Epilepsy
    Sleep Disorders
    Stroke
    Neuromuscular Disorders
    Movement Disorders
    View all Diseases
  • Topics
    Biology
    Diagnostics
    Trial Updates
    Treatment
    Prevention
    Surgery
    Imaging
    Genetics
    COVID-19
    View all Topics
  • Conferences
    AAN 2023
    BNA 2023
    AD/PD 2023
    CONy 2023
    ACTRIMS 2023
    ISC 2023
    View all Conferences
  • Features
  • Podcasts
    • About
      • Supporter
      • Expert Index
      • Editorial Board
      • Editorial Team
      • Editorial Policy
    • Contact
    • Sign up

Perspectives

Using AI to predict epilepsy surgery outcomes 6:27
Using AI to predict epilepsy surgery outcomes
Daniel Goldenholz • 28 Apr 2023
The promise of proteomics in sleep medicine 2:07
The promise of proteomics in sleep medicine
Emmanuel Mignot • 11 May 2023
Future of tau-directed therapeutics in tauopathies 2:13
Future of tau-directed therapeutics in tauopathies
Boyd Ghosh • 20 Apr 2023
Next steps in acute stroke treatment 2:34
Next steps in acute stroke treatment
Johanna Ospel • 13 Apr 2023
Future of tau-targeting immunotherapies in Alzheimer’s disease 2:07
Future of tau-targeting immunotherapies in Alzheimer’s disease
Todd Carter • 29 Mar 2023
Key questions for cell and gene therapy trials in Parkinson’s disease 2:23
Key questions for cell and gene therapy trials in Parkinson’s disease
Emma Lane • 29 Mar 2023
Importance of the patient voice in clinical trials 1:13
Importance of the patient voice in clinical trials
Emma Lane • 29 Mar 2023
Basic, clinical and translational research at CONy 3:15
Basic, clinical and translational research at CONy
Michael Ugrumov • 30 Mar 2023
Informing iRBD patients about potential PD development 1:32
Informing iRBD patients about potential PD development
Michael Ugrumov • 30 Mar 2023
Stopping clinical therapy trials because of futility: should it be allowed? 2:30
Stopping clinical therapy trials because of futility: should it be allowed?
Amos Korczyn • 9 Mar 2023
CONy: fostering lively debates in neurology 1:34
CONy: fostering lively debates in neurology
Andriy Dubenko • 6 Mar 2023
Controversies in MS: prodrome, DMTs & biomarkers 1:11
Controversies in MS: prodrome, DMTs & biomarkers
Celia Oreja-Guevara • 24 Mar 2023
Progressive MS: emerging treatments 1:42
Progressive MS: emerging treatments
Emily Evans • 21 Feb 2023
Overview of the 17th World Congress on Controversies in Neurology 3:44
Overview of the 17th World Congress on Controversies in Neurology
Amos Korczyn • 9 Mar 2023
CONy 2023: controversies in neuroimmunology, PD and AD 7:53
CONy 2023: controversies in neuroimmunology, PD and AD
Amos Korczyn • 9 Mar 2023
Improving comprehensive MS care through innovative and specialized approaches 2:34
Improving comprehensive MS care through innovative and specialized approaches
Barry Singer • 28 Feb 2023
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 36
  • Next
Journal Pages
  • Diseases
  • Topics
  • Medicines
  • Trials
  • Conferences
  • Features
Newsletter

Receive the latest news and videos from VJNeurology via email

Sign up
Contact Us

Contact us for more information

mmp logo

Magdalen Centre
The Oxford Science Park
Oxford OX4 4GA, United Kingdom

VJNeurology logo
The content of VJNeurology is intended for healthcare professionals
  • Cookie Policy
  • Privacy Policy
  • Terms of Use
  • Editorial Policy